Science vs. regulations [Regulatives / Guidelines]

posted by qualityassurance – Jordan, 2020-04-23 14:11 (180 d 10:31 ago) – Posting: # 21345
Views: 8,903

Dear Helmut and all,

Hope everyone is good and safe.

The same query raised by MoH and i want to answer. Could you help me?

» IR or MR formulation? If MR, DR or CR?
IR

» Pilot studies performed? If yes, outcome?
No

» Sampling planned based on average t½ from the literature? If yes, please give x±SD and sample size in your study.
The last two time point was 24.00 & 48.00. It was planned based on PARs (12.00 & 24.00 was the last time point in two PARs). 36 subjects

» Observed t½ (x±SD, range)?
For reference (10.03 ±4.09, 3.5-19.0)
For test (9.2 ±2.96, 3.22-17.0)

» tmax, tlast?
For reference: Tmax: 0.67, Tlast: 28.25
For test: Tmax: 0.50, Tlast: 23.91

Forgive me for the formatting. I tried my best.
Regards.

Complete thread:

Activity
 Admin contact
21,170 posts in 4,411 threads, 1,474 registered users;
online 15 (0 registered, 15 guests [including 6 identified bots]).
Forum time: Wednesday 00:42 CEST (Europe/Vienna)

But it is in matters beyond the limits of mere rule
that the skill of the analyst is evinced.
He makes in silence a host of observations and inferences…    Edgar Allan Poe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5